TY - JOUR
T1 - The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production
AU - Kobayashi, Toshihiko
AU - Shimabukuro-Demoto, Shiho
AU - Yoshida-Sugitani, Reiko
AU - Furuyama-Tanaka, Kaori
AU - Karyu, Hitomi
AU - Sugiura, Yuki
AU - Shimizu, Yukiko
AU - Hosaka, Toshiaki
AU - Goto, Motohito
AU - Kato, Norihiro
AU - Okamura, Tadashi
AU - Suematsu, Makoto
AU - Yokoyama, Shigeyuki
AU - Toyama-Sorimachi, Noriko
N1 - Funding Information:
We thank M. Tamura-Nakano (National Center for Global Health and Medicine) for technical assistance with the electron microscopy; P.M. Pitha (Johns Hopkins University) for the human IRF3-GFP and IRF7-GFP expression vectors; S. Takaki (National Center for Global Health and Medicine) for the μMT mice; T. Taniguchi (University of Tokyo) for the Irf7 −/− mice; and Y. Wada (Osaka University) and G.H. Sun-Wada (Doshisha Women’s College) for the anti-V0a2 antibody. We also thank H. Karasuyama and Y. Kawano (Tokyo Medical and Dental University), K. Miyake (University of Tokyo), L.A. Miglietta, and G.E. Gray for critical reading of this manuscript; T. Maeda (University of Tokyo) for advice regarding the mTOR pathway; and M. Shirouzu, T. Kimura-Someya, S. Saito, N. Tanimura, and H. Sorimachi for helpful discussions. This work was supported by the Funding Program for Next Generation World-Leading Researchers (Next Program; for N.T.-S., LS134), grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (for N.T.-S., 21390123, for T.K., 25871165), and a grant from the National Center for Global Health and Medicine (for N.T.-S., 23S001).
Publisher Copyright:
© 2014 Elsevier Inc.
PY - 2014/9/18
Y1 - 2014/9/18
N2 - SLC15A4 is a lysosome-resident, proton-coupled amino-acid transporter that moves histidine and oligopeptides from inside the lysosome to the cytosol of eukaryotic cells. SLC15A4 is required for Toll-like receptor 7 (TLR7)- and TLR9-mediated type I interferon (IFN-I) productions in plasmacytoid dendritic cells (pDCs) and is involved in the pathogenesis of certain diseases including lupus-like autoimmunity. How SLC15A4 contributes to diseases is largely unknown. Here we have shown that B cell SLC15A4 was crucial for TLR7-triggered IFN-I and autoantibody productions in a mouse lupus model. SLC15A4 loss disturbed the endolysosomal pH regulation and probably the v-ATPase integrity, and these changes were associated with disruption of the mTOR pathway, leading to failure of the IFN regulatory factor 7 (IRF7)-IFN-I regulatory circuit. Importantly, SLC15A4's transporter activity was necessary for the TLR-triggered cytokine production. Our findings revealed that SLC15A4-mediated optimization of the endolysosomal state is integral to a TLR7-triggered, mTOR-dependent IRF7-IFN-I circuit that leads to autoantibody production.
AB - SLC15A4 is a lysosome-resident, proton-coupled amino-acid transporter that moves histidine and oligopeptides from inside the lysosome to the cytosol of eukaryotic cells. SLC15A4 is required for Toll-like receptor 7 (TLR7)- and TLR9-mediated type I interferon (IFN-I) productions in plasmacytoid dendritic cells (pDCs) and is involved in the pathogenesis of certain diseases including lupus-like autoimmunity. How SLC15A4 contributes to diseases is largely unknown. Here we have shown that B cell SLC15A4 was crucial for TLR7-triggered IFN-I and autoantibody productions in a mouse lupus model. SLC15A4 loss disturbed the endolysosomal pH regulation and probably the v-ATPase integrity, and these changes were associated with disruption of the mTOR pathway, leading to failure of the IFN regulatory factor 7 (IRF7)-IFN-I regulatory circuit. Importantly, SLC15A4's transporter activity was necessary for the TLR-triggered cytokine production. Our findings revealed that SLC15A4-mediated optimization of the endolysosomal state is integral to a TLR7-triggered, mTOR-dependent IRF7-IFN-I circuit that leads to autoantibody production.
UR - http://www.scopus.com/inward/record.url?scp=84907962139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84907962139&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2014.08.011
DO - 10.1016/j.immuni.2014.08.011
M3 - Article
C2 - 25238095
AN - SCOPUS:84907962139
SN - 1074-7613
VL - 41
SP - 375
EP - 388
JO - Immunity
JF - Immunity
IS - 3
ER -